2022
DOI: 10.1007/s12519-022-00623-4
|View full text |Cite
|
Sign up to set email alerts
|

New epidemiological trends of respiratory syncytial virus bronchiolitis during COVID-19 pandemic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
20
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(21 citation statements)
references
References 8 publications
1
20
0
Order By: Relevance
“…From this point of view, research volumes for keywords such as Respiratory Syncytial Virus, its acronym RSV, and Bronchiolitis, did experience a sudden and substantial surge during the last week of 2021, with similar features from the analysis of the daily visualization of Wikipedia web pages. The retrieved trends mirrored some regional estimates on the incidence of RSV cases [ 66 , 67 ] and even multicentric reports [ 66 ]: compared to the pre-pandemic era, admission for Bronchiolitis sharply decreased during the first year of the SARS-CoV-2 pandemic (i.e., −87% during 2020–2021), with a substantial resurgence during the 2021–2022 (i.e., +369% compared to 2020–2021), and 1177% compared to 2021–2022. In addition, our data were affected by a similar seesaw trend, seemingly suggesting a consistent correlation with the actual circulation of the pathogen.…”
Section: Discussionsupporting
confidence: 59%
See 1 more Smart Citation
“…From this point of view, research volumes for keywords such as Respiratory Syncytial Virus, its acronym RSV, and Bronchiolitis, did experience a sudden and substantial surge during the last week of 2021, with similar features from the analysis of the daily visualization of Wikipedia web pages. The retrieved trends mirrored some regional estimates on the incidence of RSV cases [ 66 , 67 ] and even multicentric reports [ 66 ]: compared to the pre-pandemic era, admission for Bronchiolitis sharply decreased during the first year of the SARS-CoV-2 pandemic (i.e., −87% during 2020–2021), with a substantial resurgence during the 2021–2022 (i.e., +369% compared to 2020–2021), and 1177% compared to 2021–2022. In addition, our data were affected by a similar seesaw trend, seemingly suggesting a consistent correlation with the actual circulation of the pathogen.…”
Section: Discussionsupporting
confidence: 59%
“…In fact, severe acute respiratory illnesses (ARI) and LRTI definitions, which also include Bronchiolitis and Pneumonia, would represent a far better proxy for this pathogen, but again the correspondent seasonal data on the Italian population remains either fragmentary or unavailable [ 4 , 48 ]. Therefore, the lack of the actual and consistent predictive effect on research volumes for RSV and Respiratory Syncytial Virus can be explained through the inconsistency and substantial imbalance between what Public Health professionals would need to measure when dealing with RSV, and what available surveillance data actually report [ 19 , 29 , 65 , 66 , 70 ]. Not coincidentally, in the regression analysis models, search terms such as Influenza and Bronchitis were identified as significant predictors for ILI, while the visualization rates for the Wikipedia page on Bronchiolitis were characterized as negative predictors for ILI in pediatric age groups of infants (0–4 years) and children (5–14 years).…”
Section: Discussionmentioning
confidence: 99%
“…We provided only a partial view of the seasonality of RSV infections over the past 3 years, because we took into consideration only the last four months of the three study years: nevertheless, there is evidence of a spike in cases in November in 2021, earlier than the usual peak between December and February in our latitudes. It is interesting to note that previous local studies with an observational study period extended from January to December did not observe any outbreaks of RSV bronchiolitis during spring and summer 2021 [ 31 ]. Another remarkable finding is the evidence of an important reduction in RSV cases after the advent of the Omicron variant in Italy, as previously reported by Halabi et al also in the United States (USA) [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…Anyway, the spike in cases in late 2021 has challenged the Italian National Health Care System: hospital reorganization, with the provision of temporary facilities to increase the number of inpatient beds, was necessary [ 20 , 31 ], particularly within referral centers equipped with a PICU. Despite this, in our setting in 2021, some patients with less severe diseases were transferred from the referral center to other hospitals due to ED overcrowding and a lack of beds, which rarely occurred in previous years.…”
Section: Discussionmentioning
confidence: 99%
“…However, the seasonal patterns of several infectious diseases, including RSV, have been disrupted by the COVID-19 pandemic [ 3 , 4 , 5 ]. Specifically, RSV outbreaks were suppressed at the beginning of the COVID-19 pandemic (i.e., during the 2020–2021 period) [ 6 ] and resumed with irregular timing and increased magnitude from 2021–2022 onwards [ 7 , 8 ], e.g., see Japan [ 9 ], United States [ 10 ], United Kingdom [ 8 ], Turkey [ 11 ], Belgium [ 12 ] and Italy [ 13 ] in Northern Hemisphere, as well as Australia [ 14 , 15 , 16 ], New Zealand [ 17 ], Chile, Africa, Brazil [ 18 ] and other countries in the Southern Hemisphere [ 10 ]. These findings highlight the value of surveillance systems for RSV and other respiratory diseases during and after future pandemics, as the lifting of mitigation measures may result in severe outbreaks occurring with irregular timing [ 15 ].…”
Section: Introductionmentioning
confidence: 99%